UNC Project China asked individuals to submit their best propaganda for a condom use campaign in South China. See the top three posters below:
UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University’s efforts in Malawi to study and treat HIV-associated cancers.
With two new faculty hires, the new service provides specialized care to immunocompromised patients with unusual infections that require special expertise.
As we approach National HIV/AIDS Testing Day on June 27, a new call center will connect newly diagnosed North Carolinians with HIV care providers.
Better treatments for people suffering from compromised intestinal immunity may emerge from a small-animal model of human intestinal immune development.
Study published in PLoS Pathogens suggests new target for treatment and the eventual cure of HIV/AIDS
The SHEA Lectureship award is given annually to recognize the career contributions of a senior investigator in healthcare epidemiology and infection prevention and control.
Expanded partnership between UNC Project-Malawi and Malawi College of Medicine will improve the quality of clinical training in Malawi
UNC-Project Malawi staff train Malawi College of Medicine medical students in order to approve HIV clinical care in Malawi.
The University of North Carolina at Chapel Hill is leading a consortium that will help cultivate the next generation of global health clinicians and scientists, offering a 10-month training fellowship at one of 17 sites in 13 countries in Asia, Africa, and South America.
Lisa Rahangdale, MD, MPH, Assistant Professor, Department of Obstetrics and Gynecology and Director, NC Women’s Hospital Dysplasia Clinic, has received the school’s prestigious James W. Woods Junior Faculty Award.
A new study may help clarify why some people infected with HIV are better able to control the virus. It may also pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut.
Early treatment with antiretroviral therapy reduced the production of latently infected T-cells, a barrier to curing infection